
Che-Kai Tsao, MD, MS, discusses the current state of treatment for metastatic hormone-sensitive prostate cancer.
Che-Kai Tsao, MD, MS, is system chief of Solid Tumor Oncology at Northwell Health Cancer Institute.

Published: November 17th 2025 | Updated: